Generex Biotechnology Corporation’s Antigen Express Subsidiary Featured in Technology Update and Value Focus Review Issued by Scimitar Equity, LLC

BOSTON, Nov. 10, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology (Nasdaq:GNBT) announces that Scimitar Equity, LLC issues a review of Generex Biotechnology Corporation, entitled, “Breaking-out the Sum of the Parts: Antigen Express’ Novel Cancer Immunotherapy Emerges as a Jewel.”